-
1
-
-
0027456839
-
Epstein–Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells
-
Allday, M.J., Crawford, D.H., Thomas, J.A., Epstein–Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. J. Gen. Virol. 74:Pt. 3 (1993), 361–369.
-
(1993)
J. Gen. Virol.
, vol.74
, pp. 361-369
-
-
Allday, M.J.1
Crawford, D.H.2
Thomas, J.A.3
-
2
-
-
0029176520
-
The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas
-
Axelson, H., Henriksson, M., Wang, Y., Magnusson, K.P., Klein, G., The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas. Eur. J. Cancer 31A:12 (1995), 2099–2104.
-
(1995)
Eur. J. Cancer
, vol.31A
, Issue.12
, pp. 2099-2104
-
-
Axelson, H.1
Henriksson, M.2
Wang, Y.3
Magnusson, K.P.4
Klein, G.5
-
3
-
-
0034653998
-
c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover
-
Bahram, F., von der Lehr, N., Cetinkaya, C., Larsson, L.G., c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 95:6 (2000), 2104–2110.
-
(2000)
Blood
, vol.95
, Issue.6
, pp. 2104-2110
-
-
Bahram, F.1
von der Lehr, N.2
Cetinkaya, C.3
Larsson, L.G.4
-
4
-
-
59249087428
-
Assaying of autophagic protein degradation
-
Bauvy, C., Meijer, A.J., Codogno, P., Assaying of autophagic protein degradation. Methods Enzymol. 452 (2009), 47–61.
-
(2009)
Methods Enzymol.
, vol.452
, pp. 47-61
-
-
Bauvy, C.1
Meijer, A.J.2
Codogno, P.3
-
5
-
-
0032485207
-
In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome
-
Bonvini, P., Nguyen, P., Trepel, J., Neckers, L.M., In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome. Oncogene 16:9 (1998), 1131–1139.
-
(1998)
Oncogene
, vol.16
, Issue.9
, pp. 1131-1139
-
-
Bonvini, P.1
Nguyen, P.2
Trepel, J.3
Neckers, L.M.4
-
6
-
-
0035839844
-
Translocations involving c-myc and c-myc function
-
Boxer, L.M., Dang, C.V., Translocations involving c-myc and c-myc function. Oncogene 20:40 (2001), 5595–5610.
-
(2001)
Oncogene
, vol.20
, Issue.40
, pp. 5595-5610
-
-
Boxer, L.M.1
Dang, C.V.2
-
7
-
-
84882767539
-
Inhibition of mTOR signaling by quercetin in cancer treatment and prevention
-
Bruning, A., Inhibition of mTOR signaling by quercetin in cancer treatment and prevention. Anti-Cancer Agents Med. Chem. 13:7 (2013), 1025–1031.
-
(2013)
Anti-Cancer Agents Med. Chem.
, vol.13
, Issue.7
, pp. 1025-1031
-
-
Bruning, A.1
-
8
-
-
84858169363
-
PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration
-
Chaitanya, G.V., Steven, A.J., Babu, P.P., PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal., 8, 2010, 31.
-
(2010)
Cell Commun. Signal.
, vol.8
, pp. 31
-
-
Chaitanya, G.V.1
Steven, A.J.2
Babu, P.P.3
-
9
-
-
84879589788
-
The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma
-
Chatterjee, M., Andrulis, M., Stuhmer, T., Muller, E., Hofmann, C., Steinbrunn, T., Heimberger, T., Schraud, H., Kressmann, S., Einsele, H., Bargou, R.C., The PI3K/Akt signaling pathway regulates the expression of Hsp70, which critically contributes to Hsp90-chaperone function and tumor cell survival in multiple myeloma. Haematologica 98:7 (2013), 1132–1141.
-
(2013)
Haematologica
, vol.98
, Issue.7
, pp. 1132-1141
-
-
Chatterjee, M.1
Andrulis, M.2
Stuhmer, T.3
Muller, E.4
Hofmann, C.5
Steinbrunn, T.6
Heimberger, T.7
Schraud, H.8
Kressmann, S.9
Einsele, H.10
Bargou, R.C.11
-
10
-
-
84899693331
-
Roles of the PI3K/Akt pathway in Epstein–Barr virus-induced cancers and therapeutic implications
-
Chen, J., Roles of the PI3K/Akt pathway in Epstein–Barr virus-induced cancers and therapeutic implications. World J. Virol. 1:6 (2012), 154–161.
-
(2012)
World J. Virol.
, vol.1
, Issue.6
, pp. 154-161
-
-
Chen, J.1
-
11
-
-
0030945675
-
Molecular mechanisms in the antiproliferative action of quercetin
-
Csokay, B., Prajda, N., Weber, G., Olah, E., Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 60:24 (1997), 2157–2163.
-
(1997)
Life Sci.
, vol.60
, Issue.24
, pp. 2157-2163
-
-
Csokay, B.1
Prajda, N.2
Weber, G.3
Olah, E.4
-
12
-
-
0032995613
-
Epstein–Barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression
-
Fujiwara, S., Nitadori, Y., Nakamura, H., Nagaishi, T., Ono, Y., Epstein–Barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression. J. Virol. 73:6 (1999), 5214–5219.
-
(1999)
J. Virol.
, vol.73
, Issue.6
, pp. 5214-5219
-
-
Fujiwara, S.1
Nitadori, Y.2
Nakamura, H.3
Nagaishi, T.4
Ono, Y.5
-
13
-
-
84929940889
-
High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity
-
Garufi, A., D'Orazi, G., High glucose dephosphorylates serine 46 and inhibits p53 apoptotic activity. J. Exp. Clin. Cancer Res., 33, 2014, 79.
-
(2014)
J. Exp. Clin. Cancer Res.
, vol.33
, pp. 79
-
-
Garufi, A.1
D'Orazi, G.2
-
14
-
-
79959266277
-
Quercetin and cancer chemoprevention
-
Gibellini, L., Pinti, M., Nasi, M., Montagna, J.P., De Biasi, S., Roat, E., Bertoncelli, L., Cooper, E.L., Cossarizza, A., Quercetin and cancer chemoprevention. Evid. Based Complement. Altern. Med., 2011, 2011, 591356.
-
(2011)
Evid. Based Complement. Altern. Med.
, vol.2011
, pp. 591356
-
-
Gibellini, L.1
Pinti, M.2
Nasi, M.3
Montagna, J.P.4
De Biasi, S.5
Roat, E.6
Bertoncelli, L.7
Cooper, E.L.8
Cossarizza, A.9
-
15
-
-
30344482578
-
c-Myc inhibition negatively impacts lymphoma growth
-
discussion 207–211
-
Gomez-Curet, I., Perkins, R.S., Bennett, R., Feidler, K.L., Dunn, S.P., Krueger, L.J., c-Myc inhibition negatively impacts lymphoma growth. J. Pediatr. Surg. 41:1 (2006), 207–211 discussion 207–211.
-
(2006)
J. Pediatr. Surg.
, vol.41
, Issue.1
, pp. 207-211
-
-
Gomez-Curet, I.1
Perkins, R.S.2
Bennett, R.3
Feidler, K.L.4
Dunn, S.P.5
Krueger, L.J.6
-
16
-
-
84881080283
-
HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma
-
Granato, M., Lacconi, V., Peddis, M., Lotti, L.V., Di Renzo, L., Gonnella, R., Santarelli, R., Trivedi, P., Frati, L., D'Orazi, G., Faggioni, A., Cirone, M., HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma. Cell. Death. Dis., 4, 2013, e730.
-
(2013)
Cell. Death. Dis.
, vol.4
, pp. e730
-
-
Granato, M.1
Lacconi, V.2
Peddis, M.3
Lotti, L.V.4
Di Renzo, L.5
Gonnella, R.6
Santarelli, R.7
Trivedi, P.8
Frati, L.9
D'Orazi, G.10
Faggioni, A.11
Cirone, M.12
-
17
-
-
84933073693
-
Targeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and future
-
Granato, M., Santarelli, R., Gonnella, R., Farina, A., Trivedi, P., Faggioni, A., Cirone, M., Targeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and future. BioMed Res. Int., 2015, 2015, 104912.
-
(2015)
BioMed Res. Int.
, vol.2015
, pp. 104912
-
-
Granato, M.1
Santarelli, R.2
Gonnella, R.3
Farina, A.4
Trivedi, P.5
Faggioni, A.6
Cirone, M.7
-
18
-
-
0034059667
-
c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells
-
Gregory, M.A., Hann, S.R., c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol. Cell. Biol. 20:7 (2000), 2423–2435.
-
(2000)
Mol. Cell. Biol.
, vol.20
, Issue.7
, pp. 2423-2435
-
-
Gregory, M.A.1
Hann, S.R.2
-
19
-
-
0347695988
-
Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization
-
Gregory, M.A., Qi, Y., Hann, S.R., Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J. Biol. Chem. 278:51 (2003), 51606–51612.
-
(2003)
J. Biol. Chem.
, vol.278
, Issue.51
, pp. 51606-51612
-
-
Gregory, M.A.1
Qi, Y.2
Hann, S.R.3
-
20
-
-
33645836334
-
The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway
-
Gulati, N., Laudet, B., Zohrabian, V.M., Murali, R., Jhanwar-Uniyal, M., The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res. 26:2A (2006), 1177–1181.
-
(2006)
Anticancer Res.
, vol.26
, Issue.2A
, pp. 1177-1181
-
-
Gulati, N.1
Laudet, B.2
Zohrabian, V.M.3
Murali, R.4
Jhanwar-Uniyal, M.5
-
21
-
-
0021688655
-
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells
-
Hann, S.R., Eisenman, R.N., Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells. Mol. Cell. Biol. 4:11 (1984), 2486–2497.
-
(1984)
Mol. Cell. Biol.
, vol.4
, Issue.11
, pp. 2486-2497
-
-
Hann, S.R.1
Eisenman, R.N.2
-
22
-
-
14644396659
-
A conserved element in Myc that negatively regulates its proapoptotic activity
-
Herbst, A., Hemann, M.T., Tworkowski, K.A., Salghetti, S.E., Lowe, S.W., Tansey, W.P., A conserved element in Myc that negatively regulates its proapoptotic activity. EMBO Rep. 6:2 (2005), 177–183.
-
(2005)
EMBO Rep.
, vol.6
, Issue.2
, pp. 177-183
-
-
Herbst, A.1
Hemann, M.T.2
Tworkowski, K.A.3
Salghetti, S.E.4
Lowe, S.W.5
Tansey, W.P.6
-
23
-
-
84876084273
-
Targeting heat shock proteins in cancer
-
Jego, G., Hazoume, A., Seigneuric, R., Garrido, C., Targeting heat shock proteins in cancer. Cancer Lett. 332:2 (2013), 275–285.
-
(2013)
Cancer Lett.
, vol.332
, Issue.2
, pp. 275-285
-
-
Jego, G.1
Hazoume, A.2
Seigneuric, R.3
Garrido, C.4
-
24
-
-
41849140001
-
Mechanisms of MYC stabilization in human malignancies
-
Junttila, M.R., Westermarck, J., Mechanisms of MYC stabilization in human malignancies. Cell Cycle 7:5 (2008), 592–596.
-
(2008)
Cell Cycle
, vol.7
, Issue.5
, pp. 592-596
-
-
Junttila, M.R.1
Westermarck, J.2
-
25
-
-
42349087843
-
Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy
-
Kelly, G.L., Rickinson, A.B., Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematology, 2007, 277–284.
-
(2007)
Hematology
, pp. 277-284
-
-
Kelly, G.L.1
Rickinson, A.B.2
-
26
-
-
85013763791
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
-
Klionsky, D.J., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1 (2016), 1–222.
-
(2016)
Autophagy
, vol.12
, Issue.1
, pp. 1-222
-
-
Klionsky, D.J.1
-
27
-
-
33845226377
-
Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry
-
Kumar, A., Marques, M., Carrera, A.C., Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry. Mol. Cell. Biol. 26:23 (2006), 9116–9125.
-
(2006)
Mol. Cell. Biol.
, vol.26
, Issue.23
, pp. 9116-9125
-
-
Kumar, A.1
Marques, M.2
Carrera, A.C.3
-
28
-
-
84946403888
-
RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin
-
Lin, C.W., Lai, G.M., Chen, K.C., Lin, T.H., Fan, J.J., Hsu, R.L., Chou, C.M., Lin, C.M., Kandaswami, C.C., Lee, M.T., Cheng, C.H., RPS12 increases the invasiveness in cervical cancer activated by c-Myc and inhibited by the dietary flavonoids luteolin and quercetin. J. Funct. Foods 19 (2015), 236–247.
-
(2015)
J. Funct. Foods
, vol.19
, pp. 236-247
-
-
Lin, C.W.1
Lai, G.M.2
Chen, K.C.3
Lin, T.H.4
Fan, J.J.5
Hsu, R.L.6
Chou, C.M.7
Lin, C.M.8
Kandaswami, C.C.9
Lee, M.T.10
Cheng, C.H.11
-
29
-
-
0034836506
-
Flavonoids: a review of probable mechanisms of action and potential applications
-
Nijveldt, R.J., van Nood, E., van Hoorn, D.E., Boelens, P.G., van Norren, K., van Leeuwen, P.A., Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 74:4 (2001), 418–425.
-
(2001)
Am. J. Clin. Nutr.
, vol.74
, Issue.4
, pp. 418-425
-
-
Nijveldt, R.J.1
van Nood, E.2
van Hoorn, D.E.3
Boelens, P.G.4
van Norren, K.5
van Leeuwen, P.A.6
-
30
-
-
72849120988
-
miR-19 is a key oncogenic component of mir-17-92
-
Olive, V., Bennett, M.J., Walker, J.C., Ma, C., Jiang, I., Cordon-Cardo, C., Li, Q.J., Lowe, S.W., Hannon, G.J., He, L., miR-19 is a key oncogenic component of mir-17-92. Genes. Dev. 23:24 (2009), 2839–2849.
-
(2009)
Genes. Dev.
, vol.23
, Issue.24
, pp. 2839-2849
-
-
Olive, V.1
Bennett, M.J.2
Walker, J.C.3
Ma, C.4
Jiang, I.5
Cordon-Cardo, C.6
Li, Q.J.7
Lowe, S.W.8
Hannon, G.J.9
He, L.10
-
31
-
-
34447092454
-
Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells
-
Psahoulia, F.H., Moumtzi, S., Roberts, M.L., Sasazuki, T., Shirasawa, S., Pintzas, A., Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells. Carcinogenesis 28:5 (2007), 1021–1031.
-
(2007)
Carcinogenesis
, vol.28
, Issue.5
, pp. 1021-1031
-
-
Psahoulia, F.H.1
Moumtzi, S.2
Roberts, M.L.3
Sasazuki, T.4
Shirasawa, S.5
Pintzas, A.6
-
32
-
-
0021279267
-
Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma
-
Rabbitts, T.H., Forster, A., Hamlyn, P., Baer, R., Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma. Nature 309:5969 (1984), 592–597.
-
(1984)
Nature
, vol.309
, Issue.5969
, pp. 592-597
-
-
Rabbitts, T.H.1
Forster, A.2
Hamlyn, P.3
Baer, R.4
-
33
-
-
0027318202
-
Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53
-
Ramqvist, T., Magnusson, K.P., Wang, Y., Szekely, L., Klein, G., Wiman, K.G., Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Oncogene 8:6 (1993), 1495–1500.
-
(1993)
Oncogene
, vol.8
, Issue.6
, pp. 1495-1500
-
-
Ramqvist, T.1
Magnusson, K.P.2
Wang, Y.3
Szekely, L.4
Klein, G.5
Wiman, K.G.6
-
34
-
-
84860755726
-
The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation
-
Rao, E., Jiang, C., Ji, M., Huang, X., Iqbal, J., Lenz, G., Wright, G., Staudt, L.M., Zhao, Y., McKeithan, T.W., Chan, W.C., Fu, K., The miRNA-17 approximately 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia 26:5 (2012), 1064–1072.
-
(2012)
Leukemia
, vol.26
, Issue.5
, pp. 1064-1072
-
-
Rao, E.1
Jiang, C.2
Ji, M.3
Huang, X.4
Iqbal, J.5
Lenz, G.6
Wright, G.7
Staudt, L.M.8
Zhao, Y.9
McKeithan, T.W.10
Chan, W.C.11
Fu, K.12
-
35
-
-
84870948750
-
Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy
-
Rodriguez, O.C., Choudhury, S., Kolukula, V., Vietsch, E.E., Catania, J., Preet, A., Reynoso, K., Bargonetti, J., Wellstein, A., Albanese, C., Avantaggiati, M.L., Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy. Cell Cycle 11:23 (2012), 4436–4446.
-
(2012)
Cell Cycle
, vol.11
, Issue.23
, pp. 4436-4446
-
-
Rodriguez, O.C.1
Choudhury, S.2
Kolukula, V.3
Vietsch, E.E.4
Catania, J.5
Preet, A.6
Reynoso, K.7
Bargonetti, J.8
Wellstein, A.9
Albanese, C.10
Avantaggiati, M.L.11
-
36
-
-
0032980719
-
Epstein–Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma
-
Ruf, I.K., Rhyne, P.W., Yang, H., Borza, C.M., Hutt-Fletcher, L.M., Cleveland, J.L., Sample, J.T., Epstein–Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol. Cell. Biol. 19:3 (1999), 1651–1660.
-
(1999)
Mol. Cell. Biol.
, vol.19
, Issue.3
, pp. 1651-1660
-
-
Ruf, I.K.1
Rhyne, P.W.2
Yang, H.3
Borza, C.M.4
Hutt-Fletcher, L.M.5
Cleveland, J.L.6
Sample, J.T.7
-
37
-
-
84872822693
-
Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells
-
Sander, S., Rajewsky, K., Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells. Oncotarget 3:10 (2012), 1066–1067.
-
(2012)
Oncotarget
, vol.3
, Issue.10
, pp. 1066-1067
-
-
Sander, S.1
Rajewsky, K.2
-
38
-
-
84865114403
-
Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis
-
Sander, S., Calado, D.P., Srinivasan, L., Kochert, K., Zhang, B., Rosolowski, M., Rodig, S.J., Holzmann, K., Stilgenbauer, S., Siebert, R., Bullinger, L., Rajewsky, K., Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 22:2 (2012), 167–179.
-
(2012)
Cancer Cell
, vol.22
, Issue.2
, pp. 167-179
-
-
Sander, S.1
Calado, D.P.2
Srinivasan, L.3
Kochert, K.4
Zhang, B.5
Rosolowski, M.6
Rodig, S.J.7
Holzmann, K.8
Stilgenbauer, S.9
Siebert, R.10
Bullinger, L.11
Rajewsky, K.12
-
39
-
-
84867051939
-
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
-
Schmitz, R., Young, R.M., Ceribelli, M., Jhavar, S., Xiao, W., Zhang, M., Wright, G., Shaffer, A.L., Hodson, D.J., Buras, E., Liu, X., Powell, J., Yang, Y., Xu, W., Zhao, H., Kohlhammer, H., Rosenwald, A., Kluin, P., Muller-Hermelink, H.K., Ott, G., Gascoyne, R.D., Connors, J.M., Rimsza, L.M., Campo, E., Jaffe, E.S., Delabie, J., Smeland, E.B., Ogwang, M.D., Reynolds, S.J., Fisher, R.I., Braziel, R.M., Tubbs, R.R., Cook, J.R., Weisenburger, D.D., Chan, W.C., Pittaluga, S., Wilson, W., Waldmann, T.A., Rowe, M., Mbulaiteye, S.M., Rickinson, A.B., Staudt, L.M., Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490:7418 (2012), 116–120.
-
(2012)
Nature
, vol.490
, Issue.7418
, pp. 116-120
-
-
Schmitz, R.1
Young, R.M.2
Ceribelli, M.3
Jhavar, S.4
Xiao, W.5
Zhang, M.6
Wright, G.7
Shaffer, A.L.8
Hodson, D.J.9
Buras, E.10
Liu, X.11
Powell, J.12
Yang, Y.13
Xu, W.14
Zhao, H.15
Kohlhammer, H.16
Rosenwald, A.17
Kluin, P.18
Muller-Hermelink, H.K.19
Ott, G.20
Gascoyne, R.D.21
Connors, J.M.22
Rimsza, L.M.23
Campo, E.24
Jaffe, E.S.25
Delabie, J.26
Smeland, E.B.27
Ogwang, M.D.28
Reynolds, S.J.29
Fisher, R.I.30
Braziel, R.M.31
Tubbs, R.R.32
Cook, J.R.33
Weisenburger, D.D.34
Chan, W.C.35
Pittaluga, S.36
Wilson, W.37
Waldmann, T.A.38
Rowe, M.39
Mbulaiteye, S.M.40
Rickinson, A.B.41
Staudt, L.M.42
more..
-
40
-
-
84891764795
-
Oncogenic mechanisms in Burkitt lymphoma
-
Schmitz, R., Ceribelli, M., Pittaluga, S., Wright, G., Staudt, L.M., Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harbor Perspect. Med., 4(2), 2014.
-
(2014)
Cold Spring Harbor Perspect. Med.
, vol.4
, Issue.2
-
-
Schmitz, R.1
Ceribelli, M.2
Pittaluga, S.3
Wright, G.4
Staudt, L.M.5
-
41
-
-
0141765902
-
New insights into the pathophysiology of multiple myeloma
-
Seidl, S., Kaufmann, H., Drach, J., New insights into the pathophysiology of multiple myeloma. Lancet Oncol. 4:9 (2003), 557–564.
-
(2003)
Lancet Oncol.
, vol.4
, Issue.9
, pp. 557-564
-
-
Seidl, S.1
Kaufmann, H.2
Drach, J.3
-
42
-
-
34047205431
-
Mutant p53: an oncogenic transcription factor
-
Strano, S., Dell'Orso, S., Di Agostino, S., Fontemaggi, G., Sacchi, A., Blandino, G., Mutant p53: an oncogenic transcription factor. Oncogene 26:15 (2007), 2212–2219.
-
(2007)
Oncogene
, vol.26
, Issue.15
, pp. 2212-2219
-
-
Strano, S.1
Dell'Orso, S.2
Di Agostino, S.3
Fontemaggi, G.4
Sacchi, A.5
Blandino, G.6
-
43
-
-
0025726282
-
An Epstein–Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA
-
Takada, K., Horinouchi, K., Ono, Y., Aya, T., Osato, T., Takahashi, M., Hayasaka, S., An Epstein–Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:2 (1991), 147–156.
-
(1991)
Virus Genes
, vol.5
, Issue.2
, pp. 147-156
-
-
Takada, K.1
Horinouchi, K.2
Ono, Y.3
Aya, T.4
Osato, T.5
Takahashi, M.6
Hayasaka, S.7
-
44
-
-
84881061593
-
Chaperone-mediated autophagy degrades mutant p53
-
Vakifahmetoglu-Norberg, H., Kim, M., Xia, H.G., Iwanicki, M.P., Ofengeim, D., Coloff, J.L., Pan, L., Ince, T.A., Kroemer, G., Brugge, J.S., Yuan, J., Chaperone-mediated autophagy degrades mutant p53. Genes. Dev. 27:15 (2013), 1718–1730.
-
(2013)
Genes. Dev.
, vol.27
, Issue.15
, pp. 1718-1730
-
-
Vakifahmetoglu-Norberg, H.1
Kim, M.2
Xia, H.G.3
Iwanicki, M.P.4
Ofengeim, D.5
Coloff, J.L.6
Pan, L.7
Ince, T.A.8
Kroemer, G.9
Brugge, J.S.10
Yuan, J.11
-
45
-
-
79951506297
-
Lymphomas differ in their dependence on Epstein–Barr virus
-
Vereide, D.T., Sugden, B., Lymphomas differ in their dependence on Epstein–Barr virus. Blood 117:6 (2011), 1977–1985.
-
(2011)
Blood
, vol.117
, Issue.6
, pp. 1977-1985
-
-
Vereide, D.T.1
Sugden, B.2
-
46
-
-
80052188068
-
Targeting heat shock proteins 70/90 and proteasome for cancer therapy
-
Wang, R.E., Targeting heat shock proteins 70/90 and proteasome for cancer therapy. Curr. Med. Chem. 18:27 (2011), 4250–4264.
-
(2011)
Curr. Med. Chem.
, vol.18
, Issue.27
, pp. 4250-4264
-
-
Wang, R.E.1
-
47
-
-
84920415711
-
The role for autophagy in cancer
-
White, E., The role for autophagy in cancer. J. Clin. Invest. 125:1 (2015), 42–46.
-
(2015)
J. Clin. Invest.
, vol.125
, Issue.1
, pp. 42-46
-
-
White, E.1
-
48
-
-
0021680288
-
Activation of a translocated c-myc gene: role of structural alterations in the upstream region
-
Wiman, K.G., Clarkson, B., Hayday, A.C., Saito, H., Tonegawa, S., Hayward, W.S., Activation of a translocated c-myc gene: role of structural alterations in the upstream region. Proc. Natl. Acad. Sci. U. S. A. 81:21 (1984), 6798–6802.
-
(1984)
Proc. Natl. Acad. Sci. U. S. A.
, vol.81
, Issue.21
, pp. 6798-6802
-
-
Wiman, K.G.1
Clarkson, B.2
Hayday, A.C.3
Saito, H.4
Tonegawa, S.5
Hayward, W.S.6
-
49
-
-
39749163245
-
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
-
Xiao, C., Srinivasan, L., Calado, D.P., Patterson, H.C., Zhang, B., Wang, J., Henderson, J.M., Kutok, J.L., Rajewsky, K., Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9:4 (2008), 405–414.
-
(2008)
Nat. Immunol.
, vol.9
, Issue.4
, pp. 405-414
-
-
Xiao, C.1
Srinivasan, L.2
Calado, D.P.3
Patterson, H.C.4
Zhang, B.5
Wang, J.6
Henderson, J.M.7
Kutok, J.L.8
Rajewsky, K.9
-
50
-
-
80053357507
-
Molecular basis for the actions of Hsp90 inhibitors and cancer therapy
-
Yamaki, H., Nakajima, M., Shimotohno, K.W., Tanaka, N., Molecular basis for the actions of Hsp90 inhibitors and cancer therapy. J. Antibiot. 64:9 (2011), 635–644.
-
(2011)
J. Antibiot.
, vol.64
, Issue.9
, pp. 635-644
-
-
Yamaki, H.1
Nakajima, M.2
Shimotohno, K.W.3
Tanaka, N.4
-
51
-
-
35448932301
-
Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines
-
Zanini, C., Giribaldi, G., Mandili, G., Carta, F., Crescenzio, N., Bisaro, B., Doria, A., Foglia, L., di Montezemolo, L.C., Timeus, F., Turrini, F., Inhibition of heat shock proteins (HSP) expression by quercetin and differential doxorubicin sensitization in neuroblastoma and Ewing's sarcoma cell lines. J. Neurochem. 103:4 (2007), 1344–1354.
-
(2007)
J. Neurochem.
, vol.103
, Issue.4
, pp. 1344-1354
-
-
Zanini, C.1
Giribaldi, G.2
Mandili, G.3
Carta, F.4
Crescenzio, N.5
Bisaro, B.6
Doria, A.7
Foglia, L.8
di Montezemolo, L.C.9
Timeus, F.10
Turrini, F.11
-
52
-
-
84924969034
-
HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma
-
Zappasodi, R., Ruggiero, G., Guarnotta, C., Tortoreto, M., Tringali, C., Cavane, A., Cabras, A.D., Castagnoli, L., Venerando, B., Zaffaroni, N., Gianni, A.M., De Braud, F., Tripodo, C., Pupa, S.M., Di Nicola, M., HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma. Blood 125:11 (2015), 1768–1771.
-
(2015)
Blood
, vol.125
, Issue.11
, pp. 1768-1771
-
-
Zappasodi, R.1
Ruggiero, G.2
Guarnotta, C.3
Tortoreto, M.4
Tringali, C.5
Cavane, A.6
Cabras, A.D.7
Castagnoli, L.8
Venerando, B.9
Zaffaroni, N.10
Gianni, A.M.11
De Braud, F.12
Tripodo, C.13
Pupa, S.M.14
Di Nicola, M.15
|